43
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Separation of Viable from Non-Viable Tumor Cells Using Ficoll-Hypaque Density Solution

, &
Pages 463-472 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nur-Afidah Mohamed Suhaimi & Min-Han Tan. (2016) Circulating Tumor Cells and Circulating Tumor DNA in Colorectal Cancer. Expert Review of Precision Medicine and Drug Development 1:2, pages 181-194.
Read now

Articles from other publishers (16)

Tarun Ghose, Soldano Ferrone, A. Huntley Blair, Yaroslav Kralovec, Massimo Temponi, Mandip Singh & Moll Mammen. (1991) Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen. Cancer Immunology Immunotherapy 34:2, pages 90-96.
Crossref
Robert A. SchwartzKrzysztof Dabski & Frederick Helm. 1988. Skin Cancer. Skin Cancer 363 377 .
Alexander Walle, Tetsuro Kodama & Myron R. Melamed. (2005) A simple density gradient for enriching subfractions of solid tumor cells. Cytometry 3:6, pages 402-407.
Crossref
Joy L. Ware, David F. Paulson, George H. Mickey & Karen S. Webb. (1982) Spontaneous Metastasis of Cells of the Human Prostate Carcinoma Cell Line PC-3 in Athymic Nude Mice. Journal of Urology 128:5, pages 1064-1067.
Crossref
G. V. Sherbet, M. S. Lakshmi, G. P. Risely, S. A. Shah & M. E. Tindle. (1982) Antigenic differences between a primary hamster lymphosarcoma and its liver metastases. Experientia 38:5, pages 610-611.
Crossref
Raul C. Braylan, Neal A. Benson, Virginia Nourse & Howard S. Kruth. (2005) Correlated analysis of cellular DNA, membrane antigens and light scatter of human lymphoid cells. Cytometry 2:5, pages 337-343.
Crossref
Shashi Shrivastav, Yousuf Sharief, John Day, Charles F. Reich & Robert A. Bonar. (1981) Establishment and characterization of a cell line (SS78) from a human renal cell carcinoma. In Vitro 17:12, pages 1117-1124.
Crossref
Robert B. Livingston. 1981. Breast Cancer 4. Breast Cancer 4 1 32 .
G.V. Sherbet, M.S. Lakshmi & D. Guy. (1980) A possibility of predicting metastatic ability of tumours by implantation into chick embryos. European Journal of Cancer (1965) 16:4, pages 561-568.
Crossref
G. V. Sherbet & M. S. Lakshmi. 1980. Metastasis. Metastasis 38 44 .
Thomas G. PretlowIIII & Theresa P. Pretlow. 1980. In Situ Expression of Tumor Immunity. In Situ Expression of Tumor Immunity 21 59 .
Haim Biran, Giona M. Mavligit & Joel L. Moake. (2006) Receptor sites for complement and for immune complexes on human nonhemopoietic tumor cells. Cancer 44:1, pages 131-135.
Crossref
M.J.D. Anderson & J.F.T. Griffin. (1979) Taenia crassiceps in the rat: Transfer of immunity and immunocompetence with lymph node cells. International Journal for Parasitology 9:3, pages 235-239.
Crossref
Sudhir A. Shah & John A. Dickson. (1978) Preservation of enzymatically prepared rabbit VX2 tumour cells in vitro. European Journal of Cancer (1965) 14:4, pages 447-448.
Crossref
Roy S. Weiner. (1976) Cryopreservation of lymphocytes for use in in vitro assays of cellular immunity. Journal of Immunological Methods 10:1, pages 49-60.
Crossref
Marius Teodorescu, Eugene P. Mayer & Sheldon Dray. (1975) A simple radioimmunoassay for the enumeration of rosette-forming cells. Journal of Immunological Methods 8:1-2, pages 127-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.